About
Kamedis develops effective, dermatologist-tested, botanical skin care products for a variety of chronic skin conditions including eczema, acne, dandruff, psoriasis, dry skin, and itchy/irritated skin. The company's botanicals are produced in a certified manufacturing facility, ensuring the quality and production consistency of the botanical extracts. The extraction technique is developed to maximize formulation potency. All final products have been validated by dermatologists, backed by dozens of clinical trials, and received strong endorsement from consumers. Launched in Israel in 2003 and now also sold in the United States, China, Taiwan, the Philippines, Singapore, and several European countries, the company's products are based on extensive scientific research and development, which included hundreds of traditional Chinese medicine botanicals and their combinations.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Kamedis founded and where is its headquarters located?
- Kamedis was founded in January 2003 and is headquartered in Tel Aviv-Yafo, Israel.
- What is Kamedis's primary business focus?
- Kamedis develops dermatologist-tested, botanical skin care products for chronic skin conditions such as eczema, acne, dandruff, psoriasis, dry skin, and itchy/irritated skin.
- In which international markets does Kamedis operate?
- Kamedis products are sold in the United States, China, Taiwan, the Philippines, Singapore, and several European countries, in addition to Israel.
- What is the basis of Kamedis's product development?
- Kamedis's products are based on extensive scientific research and development, incorporating hundreds of traditional Chinese medicine botanicals and their combinations.
- What was a significant development for Kamedis in January 2019?
- In January 2019, Kamedis received a Notice of Allowance for its first US patent related to botanical eczema treatment.
- When did Kamedis launch its products in the US market?
- Kamedis launched its botanical personal care line for eczema, acne, and dandruff in the US in February 2018.
- What was the finding of a Kamedis clinical study in April 2019?
- In April 2019, a Kamedis clinical study validated the efficacy of traditional Chinese botanicals in eczema treatment.
- What is the approximate employee count for Kamedis?
- Kamedis has approximately 42 employees.
- Who is a founder of Kamedis?
- Roni Kramer is a founder of Kamedis.